Better High-Yield Dividend Stock: Altria or British American Tobacco?

Altria (MO) and British American Tobacco (BTI), both yielding around 7%, are leading dividend stocks in the sin stock category; however, British American Tobacco is better positioned for long-term growth. While both companies are adapting to the shift from traditional cigarettes to smokeless nicotine products, British American Tobacco's Vuse brand has captured significant market share, while Altria lags behind in the smokeless sector, making British American Tobacco the superior high-yield stock.

Analysis

Altria Group (MO) and British American Tobacco (BTI) are prominent tobacco companies offering high dividend yields, currently around 7%, supported by resilient business models and substantial free cash flow. While appearing financially similar with nearly identical dividend yields, anticipated long-term earnings growth, and valuations, their strategic adaptation to the evolving nicotine market presents a key divergence. The industry is transitioning from traditional cigarettes to smokeless nicotine products, where British American Tobacco has demonstrated superior progress. Its Vuse e-vape brand has secured an estimated 40% market share in core markets, and new product categories contributed 13.2% to its total revenue in 2024. In contrast, Altria's foray into smokeless alternatives has been less successful, highlighted by a problematic $12.8 billion e-vape investment in 2018, with its new product categories accounting for only $300 million, or 1.2% of total revenue in 2024. Altria also faces potential increased pressure from Philip Morris International's U.S. launch of its IQOS heat-not-burn product. Although a U.S. government crackdown on illegal vape products is anticipated to benefit both firms, British American Tobacco, with Vuse commanding a 50% share of the U.S. vaping market, is positioned to capitalize more effectively. Consequently, while Altria may serve as a short-term dividend play, its long-term growth trajectory appears more uncertain compared to British American Tobacco, which is adapting more effectively to the shift towards next-generation nicotine products.

Key Decisions for Investors

• Investors seeking dividend income within the tobacco sector should consider British American Tobacco's stronger positioning in the growing smokeless nicotine market, evidenced by Vuse's significant market share (40% in core markets, 50% in the U.S.) and new products contributing 13.2% to 2024 revenue, which may support more sustainable long-term dividend growth.
• Shareholders in Altria should closely monitor its ability to accelerate growth in its smokeless product segment, which currently represents only 1.2% of revenue, and assess the competitive impact of Philip Morris International's IQOS rollout in the U.S., given the ongoing erosion of traditional cigarette volumes.
• Evaluate the potential for British American Tobacco to disproportionately benefit from the U.S. regulatory crackdown on illegal vape products, which could further solidify Vuse's market leadership and enhance its revenue from next-generation products.